Production (Stage)
BioSig Technologies, Inc.
BSGM
$5.23
-$0.63-10.75%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 176.36% | -61.27% | |||
| Depreciation & Amortization | -30.00% | -3.23% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 149.50% | -59.46% | |||
| Operating Income | -152.24% | 59.90% | |||
| Income Before Tax | -154.78% | 42.58% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -154.78% | 42.58% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -155.87% | 42.58% | |||
| EBIT | -152.24% | 59.90% | |||
| EBITDA | -156.98% | 60.50% | |||
| EPS Basic | -107.67% | 45.53% | |||
| Normalized Basic EPS | -107.55% | 61.40% | |||
| EPS Diluted | -107.67% | 45.53% | |||
| Normalized Diluted EPS | -107.55% | 61.40% | |||
| Average Basic Shares Outstanding | 21.15% | 5.91% | |||
| Average Diluted Shares Outstanding | 21.15% | 5.91% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||